KAT2B Antikörper (N-Term)
Kurzübersicht für KAT2B Antikörper (N-Term) (ABIN2331209)
Target
Alle KAT2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 260-291, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- PCAF, NT (KAT2B, PCAF, Histone acetyltransferase KAT2B, Histone acetyltransferase PCAF, Lysine acetyltransferase 2B, P300/CBP-associated factor)
-
Aufreinigung
- Purified by saturated ammonium sulfate precipitation followed by dialysis against PBS.
-
Immunogen
- PCAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 260-291 amino acids from the N-terminal region of human PCAF.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))
-
Andere Bezeichnung
- PCAF
-
NCBI Accession
- NP_003875
-
UniProt
- Q92831
-
Pathways
- p53 Signalweg, Regulation of Carbohydrate Metabolic Process
Target
-